The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients.

Abstract

The main cause of death in hemodialysis patients is cardiovascular diseases. Increased arterial stiffness is a predictor of cardiovascular events for hemodialysis patients. Among the nondialysis patient population, arterial stiffness increases in those with hepatic fibrosis and nonalcoholic fatty liver disease. This study aims to examine the relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients for the first time in the literature. The study includes chronic hemodialysis patients over 18 years of age who had been treated for hemodialysis for at least 6months. Patients with chronic liver disease, chronic viral hepatitis (HBV and HCV), alcohol use, or liver disease accompanied by polycystic kidney disease and active infection were excluded. Hepatic fibrosis scores were measured using the FibroScan device. Single-cuff Mobil-o-Graph was used for measurement of arterial stiffness. Fifty-nine patients were enrolled; 54.2% of the patients were male, and the mean age was 53.9 ± 12.9years. Thirty-nine percent of the patients had diabetes. Average pulse wave velocity (PWV) value of the patients was 8.3 ± 1.6m/s, and it had positive correlation with age, CAP score, fibrosis score, and body mass index and showed negative correlation to albumin. It was seen that the patients with a PWV value ≥ 10m/s have significantly higher CAP score compared with the patients with a PWV < 10m/s. When the factors predicting PWV were examined in the regression analysis, age and systolic blood pressure were found to be determinants. Increased hepatic fibrosis in hemodialysis patients is associated with increased arterial stiffness, but this relationship is not independent.